1. Home
  2. FLNC vs EVO Comparison

FLNC vs EVO Comparison

Compare FLNC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluence Energy Inc.

FLNC

Fluence Energy Inc.

HOLD

Current Price

$11.30

Market Cap

1.8B

Sector

Miscellaneous

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.95

Market Cap

778.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLNC
EVO
Founded
2018
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
778.3M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
FLNC
EVO
Price
$11.30
$1.95
Analyst Decision
Hold
Strong Buy
Analyst Count
17
1
Target Price
$15.71
$7.00
AVG Volume (30 Days)
7.2M
46.0K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,262,830,000.00
N/A
Revenue This Year
$51.23
$1.37
Revenue Next Year
$21.30
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.60
$1.89
52 Week High
$33.51
$4.27

Technical Indicators

Market Signals
Indicator
FLNC
EVO
Relative Strength Index (RSI) 34.96 40.09
Support Level N/A $1.90
Resistance Level $15.89 $2.20
Average True Range (ATR) 0.85 0.05
MACD -0.02 0.02
Stochastic Oscillator 6.62 17.74

Price Performance

Historical Comparison
FLNC
EVO

About FLNC Fluence Energy Inc.

Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: